Article PDF
Avoid common mistakes on your manuscript.
References
Bergmeier, W. and Stefanini, L., Novel molecules in calcium signaling in platelets. J. Thromb. Haemost., 7Suppl 1, 187–190 (2009).
Canizares, C., Vivar, N., and Herdoiza, M., The effects of taxol, a potent platelet antiaggregant, may be due to its microtubular stabilization activity. Platelets, 8, 61–64 (1997).
Davì, G. and Patrono, C., Platelet activation and atherothrombosis. N. Engl. J. Med., 357, 2482–2494 (2007).
Herdeg, C., Oberhoff, M., and Karsch, K. R., Antiproliferative stent coatings: Taxol and related compounds. Semin. Interv. Cardiol., 3, 197–199 (1998).
Horwitz, S. B., Mechanism of action of taxol. Trends. Pharmacol. Sci., 13, 134–136 (1992).
Houston, D. S., Shepherd, J. T., and Vanhoutte, P. M., Adenine nucleotides, serotonin, and endothelium-dependent relaxations to platelets. Am. J. Physiol., 248, H389–395 (1985).
Ishikawa, H., Fujiwara, K., Suzuki, S., Tanaka, Y., and Kohno, I., Platelet-sparing effect of paclitaxel in heavily pretreated ovarian cancer patients. Int. J. Clin. Oncol., 7, 330–333 (2002).
Jennings, L. K., Role of platelets in atherothrombosis. Am. J. Cardiol., 103(3 Suppl), 4A–10A (2009).
Kenney, D. M. and F. C. Chao, Ionophore-induced disassembly of blood platelet microtubules: effect of cyclic AMP and indomethacin. J. Cell Physiol., 103, 289–298 (1980).
Kroll, M. H. and Schafer, A. I., Biochemical mechanisms of platelet activation. Blood, 74, 1181–1195 (1989).
Lee, J. J., Yu, J. Y., Lee, J. H., Zhang, W. Y., Kim, T. J., Myung, C. S., and Yun, Y. P., The Protective Effects of Paclitaxel on Platelet Aggregation through the Inhibition of Thromboxane A2 Synthase. Arch. Pharm. Res., 33, 387–394 (2010).
Leung, K. C., Hsin, M. K., Chan, J. S., Yip, J. H., Li, M., Leung, B. C., Mok, T. S., Warner, T. D., Underwood, M. J., and Chen, G. G., Inhibition of thromboxane synthase induces lung cancer cell death via increasing the nuclear p27. Exp. Cell Res., 315, 2974–2981 (2009).
Moussa, O., Riker, J. M., Klein, J., Fraig, M., Halushka, P. V., and Watson, D. K., Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents. Oncogene, 27, 55–62 (2008).
Moussa, O., Yordy, J. S., Abol-Enein, H., Sinha, D., Bissada, N. K., Halushka, P. V., Ghoneim, M. A., and Watson, D. K., Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res., 65, 11581–11587 (2005).
Nakahata, N., Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol. Ther., 118, 18–35 (2008).
Packham, M. A., Role of platelets in thrombosis and hemostasis. Can. J. Physiol. Pharmacol., 72, 278–284 (1994).
Pertusini, E., Ratajczak, J., Majka, M., Vaughn, D., Ratajczak, M. Z., and Gewirtz, A. M., Investigating the plateletsparing mechanism of paclitaxel/carboplatin combination chemotherapy. Blood, 97, 638–644 (2001).
Radomski, M. W., Palmer, R. M., and Moncada, S., The antiaggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol., 92, 639–646 (1987).
Reilly, M. and Fitzgerald, G. A., Cellular activation by thromboxane A2 and other eicosanoids. Eur. Heart J., 14 Suppl K, 88–93 (1993).
Sakai, H., Suzuki, T., Takahashi, Y., Ukai, M., Tauchi, K., Fujii, T., Horikawa, N., Minamimura, T., Tabuchi, Y., Morii, M., Tsukada, K., and Takeguchi, N., Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2. FEBS Lett., 580, 3368–3374 (2006).
Shiba, M., Watanabe, E., Sasakawa, S., and Ikeda, Y., Effects of taxol and colchicine on platelet membrane properties. Thromb. Res., 52, 313–323 (1988).
Steiner, M. and Ikeda, Y., Quantitative assessment of polymerized and depolymerized platelet microtubules. Changes caused by aggregating agents. J. Clin. Invest., 63, 443–448 (1979).
Vanhoutte, P. M. and Houston, D. S., Platelets, endothelium, and vasospasm. Circulation, 72, 728–734 (1985).
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., and McPhail, A. T., Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc., 93, 2325–2327 (1971).
Wild, M. D., Walle, U. K., and Walle, T., Extensive and saturable accumulation of paclitaxel by the human platelet. Cancer Chemother. Pharmacol., 36, 41–44 (1995).
Willerson, J. T., Golino, P., Eidt, J., Campbell, W. B., and Buja, L. M., Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation, 80, 198–205 (1989).
Worner, P. and Brossmer, R., Platelet aggregation and the release induced by inophores for divalent cations. Thromb. Res., 6, 295–305 (1975).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, J.Y. This Month in APR. Arch. Pharm. Res. 33, 335–337 (2010). https://doi.org/10.1007/s12272-010-0300-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-0300-8